Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Latest SPAC News: Former Rusal chief launches London’s first mining SPAC, LanzaTech partners with Northwestern, Yale and NREL to establish new biology center, and Jupiter Wellness initiates clinical trial for new treatment for tinnitus
Former Rusal chief launches London’s first mining SPAC
One of the most prominent Anglo-Russian executives in the metals industry is seeking to raise $125mn for a new mining venture through a London-listed special purpose acquisition company. Artem Volynets, former chief executive of EN+ Group, believes now is a good time for mining deals, particularly for critical metals such as copper and cobalt, despite difficult market conditions.
The new blank-check fund, ACG, is seeking to raise up to $125mn in its initial public offering on Thursday and will identify a target mine producing copper, nickel, cobalt or another metal.
LanzaTech, Northwestern University, Yale University, and NREL to Establish New Center for Multi-Scale Synthetic Biology
The U.S. Department of Energy (DOE) recently announced $178 million for bioenergy research to advance sustainable technology breakthroughs that can improve public health, address climate change, improve food and agricultural production, and create more resilient supply chains.
A team from Northwestern University, LanzaTech NZ, Inc. (LanzaTech), Yale University, and National Renewable Energy Laboratory (NREL) received $18.5 Million in funding from this grant for integrating cell?free systems and genome engineering to accelerate biosystems design for carbon?negative biomanufacturing.
LanzaTech has entered into a merger agreement for a business combination transaction with AMCI Acquisition Corp. II (Nasdaq: AMCI).
Jupiter Wellness Initiates Clinical Trial for Potential New Treatment for Tinnitus
Jupiter Wellness, Inc. (Nasdaq:JUPW), a wellness company focused on hair loss, eczema, burns, and sexual wellness announced today the initiation of a triple-blinded clinical study evaluating a possible treatment for tinnitus. To date, no effective treatment exists for tinnitus.
